Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Thromboxane Receptor Antagonist to Block the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Function (TRAP) Trial

NCT03962855 is registered in ClinicalTrials.gov with Jeffrey Rade as lead sponsor.

NCT NCT03962855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03962855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Thromboxane Receptor Antagonist to Block the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Function (TRAP) Trial
Lead sponsor
Jeffrey Rade
Phase
Phase 2
Overall status
Completed
Start date
September 20, 2019
Completion date
November 15, 2022
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, vascular dilation